Wave

Wave company information, Employees & Contact Information

Explore related pages

Related company profiles:

Wave is a leading virtual mental health solution, founded by Stanford-trained clinical psychologist Dr. Sarah Adler. We specialize in supporting a wide range of organizations, from businesses to academic institutions, through personalized mental health care and innovative technology. With an emphasis on mental health coaching, Wave offers real-time assessments, tailored coaching programs, and virtual sessions to help individuals manage stress, anxiety, and other mental health concerns. Backed by licensed therapists, our evidence-based approach ensures comprehensive support, boosting both personal well-being and organizational productivity. Wave integrates seamlessly into any organization, empowering employees and teams to thrive.

Company Details

Employees
29
Founded
-
Address
Palo Alto, Ca 94024, Us
Industry
Mental Health Care
NAICS
Offices of Mental Health Practitioners (except Physicians)
HQ
Palo Alto, CA
Looking for a particular Wave employee's phone or email?

Wave Questions

News

Wave's Reflect Launch Defines New Era of AI-Supported Mental Health Care - PR Newswire

Wave's Reflect Launch Defines New Era of AI-Supported Mental Health Care PR Newswire

Wave Life Sciences Announces Positive Update from Ongoing - GlobeNewswire

Wave Life Sciences Announces Positive Update from Ongoing GlobeNewswire

Wave RNA editing restores enzyme in genetic condition but underwhelms investors - Fierce Biotech

Wave RNA editing restores enzyme in genetic condition but underwhelms investors Fierce Biotech

Analysts Estimate Wave Life Sciences (WVE) to Report a Decline in Earnings: What to Look Out for - Yahoo Finance

Analysts Estimate Wave Life Sciences (WVE) to Report a Decline in Earnings: What to Look Out for Yahoo Finance

Wave Life Sciences: Speculative, But Promising (NASDAQ:WVE) - Seeking Alpha

Wave Life Sciences: Speculative, But Promising (NASDAQ:WVE) Seeking Alpha

Despite shrinking by US$215m in the past week, Wave Life Sciences (NASDAQ:WVE) shareholders are still up 407% over 3 years - simplywall.st

Despite shrinking by US$215m in the past week, Wave Life Sciences (NASDAQ:WVE) shareholders are still up 407% over 3 years simplywall.st

Wave Life Secures $6 Million In Investment To Increase Access To Better Mental Health Support For Gen Z - Forbes

Wave Life Secures $6 Million In Investment To Increase Access To Better Mental Health Support For Gen Z Forbes

Wave Life Sciences Ltd. (NASDAQ:WVE) Shares May Have Slumped 29% But Getting In Cheap Is Still Unlikely - beritasriwijaya.co.id

Wave Life Sciences Ltd. (NASDAQ:WVE) Shares May Have Slumped 29% But Getting In Cheap Is Still Unlikely beritasriwijaya.co.id

Wave Life Sciences Announces Initiation of Phase 1 INLIGHT Clinical Trial of WVE-007 in Obesity - GlobeNewswire

Wave Life Sciences Announces Initiation of Phase 1 INLIGHT Clinical Trial of WVE-007 in Obesity GlobeNewswire

Wave Life Sciences Achieves RNA Editing in Trial for WVE-006 in Alpha-1 Antitrypsin Deficiency - CGTLive®

Wave Life Sciences Achieves RNA Editing in Trial for WVE-006 in Alpha-1 Antitrypsin Deficiency CGTLive®

Positive news from Wave Life Sciences SELECT-HD trial - HDBuzz

Positive news from Wave Life Sciences SELECT-HD trial HDBuzz

GSK and Wave Life Sciences announce collaboration to drive discovery and development of oligonucleotide therapeutics focusing on novel genetic targets - GSK

GSK and Wave Life Sciences announce collaboration to drive discovery and development of oligonucleotide therapeutics focusing on novel genetic targets GSK

Wave Life Sciences director Henry sells $85k in shares - Investing.com

Wave Life Sciences director Henry sells $85k in shares Investing.com

Wave Life Sciences Discontinues C9orf72-ALS and Frontotemporal Dementia Agent WVE-004 After Disappointing Phase 1b/2a Findings - NeurologyLive

Wave Life Sciences Discontinues C9orf72-ALS and Frontotemporal Dementia Agent WVE-004 After Disappointing Phase 1b/2a Findings NeurologyLive

Wave Life says data are positive but stock wavers - BioWorld MedTech

Wave Life says data are positive but stock wavers BioWorld MedTech

Wave Life Sciences Announces Positive Data from FORWARD-53 Clinical Trial in DMD Including Significant Functional Benefit and Reversal of Muscle Damage after 48 Weeks of Dosing with WVE-N531 - GlobeNewswire

Wave Life Sciences Announces Positive Data from FORWARD-53 Clinical Trial in DMD Including Significant Functional Benefit and Reversal of Muscle Damage after 48 Weeks of Dosing with WVE-N531 GlobeNewswire

mpathic Receives SBIR Award to Address Racial Bias in Healthcare AI - PR Newswire

mpathic Receives SBIR Award to Address Racial Bias in Healthcare AI PR Newswire

How Much Upside is Left in Wave Life Sciences (WVE)? Wall Street Analysts Think 89.71% - Yahoo Finance

How Much Upside is Left in Wave Life Sciences (WVE)? Wall Street Analysts Think 89.71% Yahoo Finance

Wave Life Sciences Announces Submission of First Clinical - GlobeNewswire

Wave Life Sciences Announces Submission of First Clinical GlobeNewswire

Wave Life Sciences Reports Second Quarter 2025 Financial Results and Provides Business Update - GlobeNewswire

Wave Life Sciences Reports Second Quarter 2025 Financial Results and Provides Business Update GlobeNewswire

Wave Life Sciences Announces First-Ever Therapeutic RNA - GlobeNewswire

Wave Life Sciences Announces First-Ever Therapeutic RNA GlobeNewswire

Wave Life Sciences Announces Positive Interim Data from FORWARD-53 Clinical Trial Evaluating WVE-N531 in Boys with Duchenne Muscular Dystrophy Amenable to Exon 53 Skipping - GlobeNewswire

Wave Life Sciences Announces Positive Interim Data from FORWARD-53 Clinical Trial Evaluating WVE-N531 in Boys with Duchenne Muscular Dystrophy Amenable to Exon 53 Skipping GlobeNewswire

GSK Bought More Shares of Biotech Wave Life Sciences - Barron's

GSK Bought More Shares of Biotech Wave Life Sciences Barron's

Wave surfs DMD success to regulators' doors, sending stock up - Fierce Biotech

Wave surfs DMD success to regulators' doors, sending stock up Fierce Biotech

Wave Life Sciences to submit Duchenne drug for approval after Phase 2 success - The Boston Globe

Wave Life Sciences to submit Duchenne drug for approval after Phase 2 success The Boston Globe

Wave Life Sciences Ends FTD/ALS Trial of WVE-004 - AFTD - The Association for Frontotemporal Degeneration

Wave Life Sciences Ends FTD/ALS Trial of WVE-004 AFTD - The Association for Frontotemporal Degeneration

Wave Life Sciences Ltd. (NASDAQ:WVE) Shares May Have Slumped 29% But Getting In Cheap Is Still Unlikely - simplywall.st

Wave Life Sciences Ltd. (NASDAQ:WVE) Shares May Have Slumped 29% But Getting In Cheap Is Still Unlikely simplywall.st

Wave Life Sciences' Antisense Oligonucleotide WVE-003 Demonstrates Ability to Lower Mutant Huntingtin in Phase 1b/2a Trial - CGTLive®

Wave Life Sciences' Antisense Oligonucleotide WVE-003 Demonstrates Ability to Lower Mutant Huntingtin in Phase 1b/2a Trial CGTLive®

Wave Life Sciences: Positive WVE-006 Data For AATD Leads To 2025 Catalyst (NASDAQ:WVE) - Seeking Alpha

Wave Life Sciences: Positive WVE-006 Data For AATD Leads To 2025 Catalyst (NASDAQ:WVE) Seeking Alpha

Wave Life Sciences’ stock soars 51% after biotech posts positive data from Duchenne muscular-dystrophy trial - MarketWatch

Wave Life Sciences’ stock soars 51% after biotech posts positive data from Duchenne muscular-dystrophy trial MarketWatch

Wave Clinical Trial Shows First Successful RNA Editing in Humans - Genetic Engineering and Biotechnology News

Wave Clinical Trial Shows First Successful RNA Editing in Humans Genetic Engineering and Biotechnology News

Wave Life Sciences Announces Positive Results from Phase - GlobeNewswire

Wave Life Sciences Announces Positive Results from Phase GlobeNewswire

A Look at Wave Life Sciences’s (WVE) Valuation Following Excitement Over PRISM Platform Progress and RNA Pipeline Momentum - simplywall.st

A Look at Wave Life Sciences’s (WVE) Valuation Following Excitement Over PRISM Platform Progress and RNA Pipeline Momentum simplywall.st

Wave Life Sciences Announces Oral Presentation of Preclinical Data Supporting WVE-007’s Mechanism (INHBE) to Reduce Fat, Preserve Muscle, and Induce Healthy Weight Loss at ADA's Annual Scientific Sessions - GlobeNewswire

Wave Life Sciences Announces Oral Presentation of Preclinical Data Supporting WVE-007’s Mechanism (INHBE) to Reduce Fat, Preserve Muscle, and Induce Healthy Weight Loss at ADA's Annual Scientific Sessions GlobeNewswire

GSK plc acquires $22.3 million worth of Wave Life Sciences shares - Investing.com

GSK plc acquires $22.3 million worth of Wave Life Sciences shares Investing.com

Korro Bio Is Lagging Wave Life Sciences In RNA Editing. Why It Could Ultimately Lead The Space. - Investor's Business Daily

Korro Bio Is Lagging Wave Life Sciences In RNA Editing. Why It Could Ultimately Lead The Space. Investor's Business Daily

Wave Life Sciences Advances in Duchenne Muscular Dystrophy Study with WVE-N531 - TipRanks

Wave Life Sciences Advances in Duchenne Muscular Dystrophy Study with WVE-N531 TipRanks

Wave Life Sciences Announces Continued Momentum in GSK - GlobeNewswire

Wave Life Sciences Announces Continued Momentum in GSK GlobeNewswire

Better Biotech Stock: Wave Life Sciences vs. Sarepta Therapeutics - The Motley Fool

Better Biotech Stock: Wave Life Sciences vs. Sarepta Therapeutics The Motley Fool

Wave Life Sciences Announces Discontinuation of Huntington Agents WVE-120102 and WVE-120101 - NeurologyLive

Wave Life Sciences Announces Discontinuation of Huntington Agents WVE-120102 and WVE-120101 NeurologyLive

Wave Life Sciences Tumbled 19% Today, But Not Everyone’s Disappointed – Find Out Why - Stocktwits

Wave Life Sciences Tumbled 19% Today, But Not Everyone’s Disappointed – Find Out Why Stocktwits

Wave Life Sciences Announces Approval of First Clinical - GlobeNewswire

Wave Life Sciences Announces Approval of First Clinical GlobeNewswire

EarFun Wave Life review: headphones that make talented musicians sound like they’re doing nightclub karaoke - Tom's Guide

EarFun Wave Life review: headphones that make talented musicians sound like they’re doing nightclub karaoke Tom's Guide

GSK Strikes $3.3B Oligonucleotide Pact with Wave Life Sciences - BioSpace

GSK Strikes $3.3B Oligonucleotide Pact with Wave Life Sciences BioSpace

Wave Life Sciences reports data on WVE-006 in AATD mouse model - BioWorld MedTech

Wave Life Sciences reports data on WVE-006 in AATD mouse model BioWorld MedTech

Wave to Discontinue Lead Huntington’s Programs After Disappointing Clinical Data - BioSpace

Wave to Discontinue Lead Huntington’s Programs After Disappointing Clinical Data BioSpace

Wave Life Sciences Discontinues Development of Suvodirsen for DMD - Muscular Dystrophy News

Wave Life Sciences Discontinues Development of Suvodirsen for DMD Muscular Dystrophy News

Wave Life Sciences crashes as it tosses out DMD drug amid trial flop - Fierce Biotech

Wave Life Sciences crashes as it tosses out DMD drug amid trial flop Fierce Biotech

Wave Life Sciences to develop programs in rare, genetic eye diseases - BioSpectrum India

Wave Life Sciences to develop programs in rare, genetic eye diseases BioSpectrum India

Top Wave Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant